AN1.ASX: Appendix 4C & Activity Report for Q4 FY2026

Appendix 4C & Activity Report for Q4 FY2026

Stock	Anagenics Ltd (AN1.ASX)
Release Time	30 Jul 2026, 10:17 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Anagenics Ltd Q4 FY2026 Activity Report

Key Points

Improved operational performance with positive trading
Cash outflows reduced to $0.08 million in Q4 FY2026
Expects to announce maiden full-year profit for FY26

Full Summary

Anagenics Ltd (ASX: AN1) has released its Q4 FY2026 activity report, highlighting improved operational performance and positive trading results. The company reported operating cash outflows of $0.08 million for the quarter, significantly lower than the $1.6 million in the previous year. The reduction in cash outflows was driven by the resolution of outstanding creditor payments following a restructuring. The company also reported $446k in royalty revenue from the YSB product line, with total YSB royalty revenue invoiced at $1.3 million for the year. Anagenics expects to announce its maiden full-year profit for FY26, subject to the final audit.

Guidance

Operating Cash Outflows reduced to $0.08 million in Q4 FY2026, down from $1.6 million in Q4 FY2025

Outlook

Anagenics expects to announce its maiden full-year profit for FY26, subject to the final audit.